Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”

Detalles Bibliográficos
Autores principales: Singh, Padam, Kumar, Shashi Kant, Maurya, Vineet Kumar, Mehta, Basant Kumar, Ahmad, Hafsa, Dwivedi, Anil Kumar, Chaturvedi, Vinita, Thakur, Tejender S., Sinha, Sudhir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645526/
https://www.ncbi.nlm.nih.gov/pubmed/31457441
http://dx.doi.org/10.1021/acsomega.7b01966
_version_ 1783437480273379328
author Singh, Padam
Kumar, Shashi Kant
Maurya, Vineet Kumar
Mehta, Basant Kumar
Ahmad, Hafsa
Dwivedi, Anil Kumar
Chaturvedi, Vinita
Thakur, Tejender S.
Sinha, Sudhir
author_facet Singh, Padam
Kumar, Shashi Kant
Maurya, Vineet Kumar
Mehta, Basant Kumar
Ahmad, Hafsa
Dwivedi, Anil Kumar
Chaturvedi, Vinita
Thakur, Tejender S.
Sinha, Sudhir
author_sort Singh, Padam
collection PubMed
description
format Online
Article
Text
id pubmed-6645526
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-66455262019-08-27 Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope” Singh, Padam Kumar, Shashi Kant Maurya, Vineet Kumar Mehta, Basant Kumar Ahmad, Hafsa Dwivedi, Anil Kumar Chaturvedi, Vinita Thakur, Tejender S. Sinha, Sudhir ACS Omega American Chemical Society 2017-12-29 /pmc/articles/PMC6645526/ /pubmed/31457441 http://dx.doi.org/10.1021/acsomega.7b01966 Text en Copyright © 2017 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Singh, Padam
Kumar, Shashi Kant
Maurya, Vineet Kumar
Mehta, Basant Kumar
Ahmad, Hafsa
Dwivedi, Anil Kumar
Chaturvedi, Vinita
Thakur, Tejender S.
Sinha, Sudhir
Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
title Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
title_full Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
title_fullStr Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
title_full_unstemmed Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
title_short Correction to “S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope”
title_sort correction to “s-enantiomer of the antitubercular compound s006-830 complements activity of frontline tb drugs and targets biogenesis of mycobacterium tuberculosis cell envelope”
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6645526/
https://www.ncbi.nlm.nih.gov/pubmed/31457441
http://dx.doi.org/10.1021/acsomega.7b01966
work_keys_str_mv AT singhpadam correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT kumarshashikant correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT mauryavineetkumar correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT mehtabasantkumar correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT ahmadhafsa correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT dwivedianilkumar correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT chaturvedivinita correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT thakurtejenders correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope
AT sinhasudhir correctiontosenantiomeroftheantitubercularcompounds006830complementsactivityoffrontlinetbdrugsandtargetsbiogenesisofmycobacteriumtuberculosiscellenvelope

Ejemplares similares